We are monitoring the impact of COVID-19 on Europe Epigenetics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1883
Share on
Share on

Europe Epigenetics Market Research Report – Segmented By Product, KITS, Reagents, Research Area, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1883
Pages: 145

Europe Epigenetics Market Size (2021 to 2026)

The Epigenetics Market size in Europe is expected to grow at a CAGR of 13.2% and reach USD 348.26 million in 2026 from USD 187.36 million in 2021.

Factors such as increased cancer incidence and prevalence, growing funding for R&D, and increased epigenetic use in non-neoplastic diseases are a few of the significant factors promoting the European epigenetics market. According to the World Health Organization (WHO), more than 3.7 million new cancer cases and 1.9 million people die each year. Cancer is the second leading cause of death and morbidity in Europe. Epigenetics is used to study changes in gene expression that can be used to diagnose disease. Therefore, it represents a massive pool of cancer patients driving the epigenetic market.

The epigenetics market in the European region is presumed to show modest growth during the forecast period with the discovery of epigenetic drugs. Cancer epidemics and advances in technology in epigenetic research are also foreseen to drive Europe epigenetics market growth. The untapped potential of the emerging European Epigenetics Market is expected to provide various opportunities for market expansion. Advances in the epigenetic industry are focusing on the detection of methylation markers associated with cancer development. For example, the Geometrics Epi proLung BL Reflex test helps diagnose lung cancer by determining methylation of the SHOX2 biomarker gene.

However, increasing equipment costs are assumed to limit market growth, and the shortage of skilled technicians is suspected of hindering the European epigenetics market growth.

The European epigenetics market is fairly competitive and consists of several key players. In terms of market share, several vital players currently dominate the market. With the growing demand for mobile healthcare and ultrasound technology development, some small businesses have entered the European epigenetics market and have a significant share. However, the intense competition from leading players can suppress the revenue portion of new entrants.

This research report on the Europe Epigenetics Market has been segmented & sub-segmented into the following categories:

By Product: 

  • Enzymes
  • Instruments & Consumable
  • KITS
  • Reagents

By Research Area: 

  • Developmental Biology
  • Oncology
  • Drug Delivery

By Enzymes: 

  • DNA-Modifying Enzymes
  • Protein-Modifying Enzymes
  • RNA-Modifying Enzymes

By Instruments & Consumables: 

  • Mass Spectrometers
  • Next-Generation Sequencers
  • qPCR
  • Sonicators

By KITS:

  • Bisulfite Conversion KITS
  • Chip-Sequence KITS
  • RNA Sequencing KITS
  • Whole-Genome Amplification KITS
  • 5-HMC and 5-MC Analysis KITS

By Reagents:

  • Antibodies
  • Buffers
  • Histones
  • Magnetic Beads
  • Primers

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, Europe is the second-largest market owing to the stable economy and presence of market leaders. The market growth in this region is driven by the growing occurrence rate of cancer in Europe and many patient populations.

The German epigenetics market is expected to dominate the European market accounting for the highest market share during the forecast period owing to the raising funds for research and development activities towards cancer and growing collaborations and mergers among the large numbers of pharmaceutical companies for the success of improved therapeutics. Extensive usage of these epigenetic applications is increasing towards non-oncology diseases.

The UK epigenetics market is predicted to have a notable growth during the forecast period due to the growing consciousness relevant to the diseases, the early treatment diagnosis, and the increasing elder aging population. As a result, research and development activities related to examining the epigenetic base of different diseases are escalating in this region. The EpiGen Research Consortium has expanded its research facility center in Singapore to research chronic diseases like obesity and diabetes in the UK.

KEY MARKET PLAYERS:

A few of the notable companies operating in the Europe epigenetics market profiled in this report are Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc. and Zymo Research Corporation.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Enzymes                  

                                                5.1.2.1 DNA-Modifying Enzymes              

                                                5.1.2.2 Protein-Modifying Enzymes        

                                                5.1.2.3 RNA-Modifying Enzymes              

                                5.1.3 Instruments & Consumables                           

                                                5.1.3.1 Mass Spectrometers       

                                                5.1.3.2 Next-Generation Sequencers     

                                                5.1.3.3 QPCR     

                                                5.1.3.4 Sonicators            

                                                5.1.3.5 Others   

                                5.1.4 KITS                            

                                                5.1.4.1 Bisulfite Conversion KITS               

                                                5.1.4.2 Chip-Sequence KITS        

                                                5.1.4.3 RNA Sequencing KITS     

                                                5.1.4.4 Whole-Genome Amplification KITS          

                                                5.1.4.5 5-HMC and 5-MC Analysis KITS   

                                                5.1.4.6 Others   

                                5.1.5 Reagents                 

                                                5.1.5.1 Antibodies           

                                                5.1.5.2  buffers 

                                                5.1.5.3 Histones               

                                                5.1.5.4 Magnetic Beads

                                                5.1.5.5 Primers

                                                5.1.5.6 Others   

                                5.1.6  Y-o-Y Growth Analysis, By Product                              

                                5.1.7 Market Attractiveness Analysis, By Product                             

                                5.1.8  Market Share Analysis, By Product                              

                5.2 Research Area                                           

                                5.2.1 Introduction                           

                                5.2.2 Developmental Biology                     

                                5.2.3 Oncology                 

                                5.2.4 Drug Delivery                         

                                5.2.5 Y-o-Y Growth Analysis, By Research Area                  

                                5.2.6 Market Attractiveness Analysis, By Research Area                

                                5.2.7 Market Share Analysis, By Research Area                  

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Research Area             

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Research Area             

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Research Area             

                6.2 U.K                                 

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Abcam plc.                                  

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Illumina, Inc.                                              

                8.3 QIAGEN N.V.                                             

                8.4 Merck & Co.                                               

                8.5 New England Biolabs, Inc.                                    

                8.6 Zymo Research Corporation                                

                8.7 Sigma-Aldrich Corporation                                   

                8.8 Thermo Fisher Scientific, Inc.                                              

                8.9 Active Motif                                               

                8.10 Diagenode, Inc.                                      

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Epigenetics Market, By Product, From 2021 to 2026 (USD Million)
  2. Europe Enzymes Market, By Region, From 2021 to 2026 (USD Million)
  3. Europe Instruments & Consumables Market, By Region, From 2021 to 2026 (USD Million)
  4. Europe KITS Market, By Region, From 2021 to 2026 (USD Million)
  5. Europe Reagents Market, By Region, From 2021 to 2026 (USD Million)
  6. Europe Epigenetics Market, By Research area, From 2021 to 2026 (USD Million)
  7. Europe Developmental Biology Market, By Region, From 2021 to 2026 (USD Million)
  8. Europe Oncology Market, By Region, From 2021 to 2026 (USD Million)
  9. Europe Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  10. U.K. Epigenetics Market, By Product, From 2021 to 2026 (USD Million)
  11. U.K. Epigenetics Market, By Research area, From 2021 to 2026 (USD Million)
  12. Germany Epigenetics Market, By Product, From 2021 to 2026 (USD Million)
  13. Germany Epigenetics Market, By Research area, From 2021 to 2026 (USD Million)
  14. France Epigenetics Market, By Product, From 2021 to 2026 (USD Million)
  15. France Epigenetics Market, By Research area, From 2021 to 2026 (USD Million)
  16. Italy Epigenetics Market, By Product, From 2021 to 2026 (USD Million)
  17. Italy Epigenetics Market, By Research area, From 2021 to 2026 (USD Million)
  18. Spain Epigenetics Market, By Product, From 2021 to 2026 (USD Million)
  19. Spain Epigenetics Market, By Research area, From 2021 to 2026 (USD Million)
  20. Europe Epigenetics Market, By Enzymes, From 2021 to 2026 (USD Million)
  21. Europe DNA-Modifying Enzymes Market, By Region, From 2021 to 2026 (USD Million)
  22. Europe Protein-Modifying Enzymes Market, By Region, From 2021 to 2026 (USD Million)
  23. Europe RNA-Modifying Enzymes Market, By Region, From 2021 to 2026 (USD Million)
  24. U.K. Epigenetics Market, By Enzymes, From 2021 to 2026 (USD Million)
  25. Germany Epigenetics Market, By Enzymes, From 2021 to 2026 (USD Million)
  26. France Epigenetics Market, By Enzymes, From 2021 to 2026 (USD Million)
  27. Italy Epigenetics Market, By Enzymes, From 2021 to 2026 (USD Million)
  28. Spain Epigenetics Market, By Enzymes, From 2021 to 2026 (USD Million)
  29. Europe Epigenetics Market, By Instruments & Consumables , From 2021 to 2026 (USD Million)
  30. Europe Mass Spectrometers Market, By Region, From 2021 to 2026 (USD Million)
  31. Europe Next-Generation Sequencers Market, By Region, From 2021 to 2026 (USD Million)
  32. Europe QPCR Market, By Region, From 2021 to 2026 (USD Million)
  33. Europe Sonicators Market, By Region, From 2021 to 2026 (USD Million)
  34. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  35. U.K. Epigenetics Market, By Instruments & Consumables , From 2021 to 2026 (USD Million)
  36. Germany Epigenetics Market, By Instruments & Consumables , From 2021 to 2026 (USD Million)
  37. France Epigenetics Market, By Instruments & Consumables , From 2021 to 2026 (USD Million)
  38. Italy Epigenetics Market, By Instruments & Consumables , From 2021 to 2026 (USD Million)
  39. Spain Epigenetics Market, By Instruments & Consumables , From 2021 to 2026 (USD Million)
  40. Europe Epigenetics Market, By KITS, From 2021 to 2026 (USD Million)
  41. Europe Bisulfite Conversion KITS Market, By Region, From 2021 to 2026 (USD Million)
  42. Europe Chip-Sequence KITS Market, By Region, From 2021 to 2026 (USD Million)
  43. Europe RNA Sequencing KITS Market, By Region, From 2021 to 2026 (USD Million)
  44. Europe Whole-Genome Amplification KITS Market, By Region, From 2021 to 2026 (USD Million)
  45. Europe 5-HMC and 5-MC Analysis KITS Market, By Region, From 2021 to 2026 (USD Million)
  46. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  47. U.K. Epigenetics Market, By KITS, From 2021 to 2026 (USD Million)
  48. Germany Epigenetics Market, By KITS, From 2021 to 2026 (USD Million)
  49. France Epigenetics Market, By KITS, From 2021 to 2026 (USD Million)
  50. Italy Epigenetics Market, By KITS, From 2021 to 2026 (USD Million)
  51. Spain Epigenetics Market, By KITS, From 2021 to 2026 (USD Million)
  52. Europe Epigenetics Market, By Reagent, From 2021 to 2026 (USD Million)
  53. Europe Antibodies Market, By Region, From 2021 to 2026 (USD Million)
  54. Europe buffers Market, By Region, From 2021 to 2026 (USD Million)
  55. Europe Histones Market, By Region, From 2021 to 2026 (USD Million)
  56. Europe Magnetic Beads Market, By Region, From 2021 to 2026 (USD Million)
  57. Europe Primers Market, By Region, From 2021 to 2026 (USD Million)
  58. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  59. U.K. Epigenetics Market, By Reagent, From 2021 to 2026 (USD Million)
  60. Germany Epigenetics Market, By Reagent, From 2021 to 2026 (USD Million)
  61. France Epigenetics Market, By Reagent, From 2021 to 2026 (USD Million)
  62. Italy Epigenetics Market, By Reagent, From 2021 to 2026 (USD Million)
  63. Spain Epigenetics Market, By Reagent, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample